Curium Pharma

Patent cliffs & loss of exclusivity

Curium Pharma is a Paris-based company developing radiopharmaceuticals founded in 2017.

Company

Crunchbase URLhttps://www.crunchbase.com/organization/curium-pharma
LinkedIn URLhttp://www.linkedin.com/company/curiumpharma
Twitter URLhttps://twitter.com/curium_pharma
Official Websitehttp://curiumpharma.com

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. DETECTNETCOPPER CU-64 DOTATATESmall mol.Sep 2041
  2. SODIUM IODIDE I 123SODIUM IODIDE I-123Small mol.—
  3. SODIUM IODIDE I 123SODIUM IODIDE I-123Small mol.—
  4. SODIUM IODIDE I 131SODIUM IODIDE I-131Small mol.—
  5. SODIUM IODIDE I 131SODIUM IODIDE I-131Small mol.—
  6. SODIUM IODIDE I 131SODIUM IODIDE I-131Small mol.—
  7. XENON XE 133XENON XE-133Small mol.—
  8. XENON XE 133XENON XE-133Small mol.—
  9. GALLIUM CITRATE GA 67GALLIUM CITRATE GA-67Small mol.—
  10. INDIUM IN 111 CHLORIDEINDIUM IN-111 CHLORIDESmall mol.—
  11. OCTREOSCANINDIUM IN-111 PENTETREOTIDE KITSmall mol.—
  12. PHOSPHOCOL P32CHROMIC PHOSPHATE P-32Small mol.—
  13. SODIUM CHROMATE CR 51SODIUM CHROMATE CR-51Small mol.—
  14. TECHNESCAN HDPTECHNETIUM TC-99M OXIDRONATE KITSmall mol.—
  15. TECHNESCAN MAG3TECHNETIUM TC-99M MERTIATIDE KITSmall mol.—
  16. TECHNESCAN PYP KITTECHNETIUM TC-99M PYROPHOSPHATE KITSmall mol.—
  17. TECHNETIUM TC 99M SESTAMIBITECHNETIUM TC-99M SESTAMIBI KITSmall mol.—
  18. TECHNETIUM TC-99M PENTETATE KITTECHNETIUM TC-99M PENTETATE KITSmall mol.—
  19. THALLOUS CHLORIDE TL 201THALLOUS CHLORIDE TL-201Small mol.—
  20. ULTRATAGTECHNETIUM TC-99M RED BLOOD CELL KITSmall mol.—
  21. THALLOUS CHLORIDE TL 201THALLOUS CHLORIDE TL-201Small mol.—
  22. IOFLUPANE I-123IOFLUPANE I-123Small mol.—
  23. ULTRA-TECHNEKOW V4TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATORSmall mol.—
  24. ULTRA-TECHNEKOW V4TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATORSmall mol.—
  25. SODIUM IODIDE I 131SODIUM IODIDE I-131Small mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.